New members on Board

16.12.11 Swedish Pharmalink AB (Stockholm) has elected Anders Wiklund to serve as its new Chairman of the Board, which will also be strengthened by former Diamyd CEO and President Elisabeth Lindner. Pharmalink’s founder and former... more

BIA gets new chief executive

15.12.11 The British BioIndustry Association has named Glyn Edwards as its interim Chief Executive with immediate effect. Edwards stepped down as CEO of Antisoma Plc (2008-2011) in February of this year after two partnered late-stage... more

EMA chief starts working

15.12.11 The European Medicines Agency’s new Executive Director officially took the reins in mid-November. Guido Rasi, who has been Secretary General of the Italian Medicines Agency since 2008, was nominated for the five-year-term in... more

Cerenis appoints new CMO

12.12.11 French HDL therapies’ specialist Cerenis Therapeutics S.A. (Toulouse) has appointed Dr. John Paolini as its new CMO. He will be responsible for the strategic planning and exe­cution of clinical trials for Cerenis’ portfolio of... more

Creabilis strengthens management

01.10.11 Creabilis SA (Luxembourg) has strengthened its senior management team with the appointment of three experienced international pharma executives: Alex Leech joins as Vice President and Head of Finance and Operations, James Sandy... more